Ultima-CJC1295 2mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE GHRH Peptide

Introducing CJC-1295, a powerful synthetic analogue of growth hormone-releasing hormone (GHRH) made up of 30 amino acids. This remarkable peptide is designed to significantly enhance growth hormone secretion and elevate IGF-1 levels, all while preserving the natural pulsatile rhythm of GH release.

For optimal results, CJC-1295 is often combined with Ipamorelin, a GHRH that provides targeted growth hormone elevation without stimulating appetite or increasing cortisol, acetylcholine, prolactin, or aldosterone?common side effects of other peptides. Ipamorelin is known for its excellent tolerability and works synergistically with CJC-1295.

CJC-1295 also promotes deep, restorative slow-wave sleep, vital for optimal muscle growth, memory retention, and overall rejuvenation.

GHRH is naturally produced in the hypothalamus, triggering the pituitary gland to release growth hormone through its pulsatile action. However, GHRH has a very brief half-life of only a few minutes. The active portion of GHRH consists of the first 29 amino acids and is available as a synthetic peptide called Sermorelin. Sermorelin's half-life has been extended to 30 minutes, leading to the creation of CJC-1295.

CJC-1295 is further enhanced with a Drug Affinity Complex (DAC), which binds to the blood protein albumin, extending its half-life to an impressive 8 days. This version is known as CJC-1295 + DAC, while the non-DAC form mimics a more natural nightly GH spike.

Thanks to DAC's influence, CJC-1295 requires only one or two injections per week. However, this extended half-life can create a continuous stimulus for GH release from the pituitary, which may not mimic physiological conditions, possibly reducing the amplitude of GH pulses and affecting tissue stimulation.

To promote recovery, consider taking 'hormone holidays' every three to six months when using long-acting CJC-1295. During these breaks, Sermorelin can serve as an effective alternative.

These 'hormone holidays' may also help mitigate the risk of developing GH resistance, which could occur due to antibody formation against GH or down-regulation of GH receptors. While these concerns are theoretical and lack long-term study validation, it's wise to stay informed.

Possible injection site reactions (including irritation, redness, swelling, pain, itching), headaches, diarrhea, vasodilation (flushing, warmth, temporary low blood pressure), nausea, and abdominal discomfort may occur.